3D printing of biologics—what has been accomplished to date?

24. November 2023

Abstract Three-dimensional (3D) printing is a promising approach for the stabilization and delivery of non-living biologics. This versatile tool builds...

Brain-Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha-Synuclein Aggregation and Improve Behavioral Symptoms of Parkinson’s Disease

12. October 2023

Monoclonal antibodies (mAbs) hold promise for treating Parkinson's disease (PD), but their therapeutic use is hindered by poor delivery to...

A smart solution for Biopharmaceutical Development – by Hayashibara

15. May 2023

TREHALOSE SG JP, USP-NF, Ph. Eur., CP High-purity and low endotoxin injectable grade trehalose TREHALOSE SG is an injectable grade...

A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions

24. October 2021

A total of 378 novel drugs and 27 biosimilars approved by the U.S. Food and Drug Administration (FDA) between 2010...

Novel lipid-based drug delivery systems containing polymethacrylate polymers as solid carriers for sustained release of simvastatin

21. August 2019

Formulation of lipid-based drug delivery systems is recognized as a promising strategy to increase bioavailability of simvastatin (SV). The purpose...

Trehalose: A Powerful Excipient in the Formulation Toolbox – Product Information

31. May 2015

By: Ben Nelson, PhD, and Chris Wilcox Trehalose is a non-reducing disaccharide consisting of two glucose molecules linked by...

Biopharma